Figures computed from official regulatory filings — .
Ownershipinsiders 15.49% · institutions 29.37%
In EUR · as of Oct 19, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for NANOBIOTIX only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
Market information source · Oct 19, 2026
Open-market timeline · full history
19 buys2 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Gary Phillipstrack record | Buy | $259.4K | conv 57Unusual size |
| AMF |
| Gary Phillipstrack record | Buy | $26K | conv 14 | AMF |
| Gary Phillipstrack record | Buy | $29.3K | conv 22 | AMF |
| Gary Phillipstrack record | Buy | $35.4K | conv 36 | AMF |
| Laurent LEVY | Sell | $5.9M | AMF |
| Bartholomeus van Rhijntrack record | Exercise | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | AMF |
| ANNE-JULIETTE HERMANT | Exercise | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | AMF |
| Laurent LEVY | Exercise | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | AMF |
| ANNE-SOPHIE LARIVIERE | Exercise | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | AMF |
| Gary Phillipstrack record | Buy | $61.8K | conv 55ClusterFirst in 12mo | AMF |
| Bartholomeus van Rhijntrack record | Buy | $41.7K | conv 36 | AMF |
| Bartholomeus van Rhijntrack record | Buy | $13.5K | conv 37 | AMF |
| Bartholomeus van Rhijntrack record | Buy | $181.7K | conv 70Unusual size | AMF |
| Bartholomeus van Rhijntrack record | Buy | $143.1K | conv 68Unusual size | AMF |
| Bartholomeus van Rhijntrack record | Buy | $32.4K | conv 39 | AMF |
| Anne-Marie GRAFFIN | Buy | $25.8K | conv 36 | AMF |
| Bartholomeus van Rhijntrack record | Buy | $2.3K | conv 19 | AMF |
| Bartholomeus van Rhijntrack record | Buy | $6.4K | conv 37 | AMF |
| Bartholomeus van Rhijntrack record | Sell | $1.9K | AMF |
| Bartholomeus van Rhijntrack record | Buy | $9.6K | conv 37Unusual size | AMF |
| Bartholomeus van Rhijntrack record | Buy | $100.7K | conv 35 | AMF |
| Bartholomeus van Rhijntrack record | Buy | $20K | conv 19 | AMF |
| Bartholomeus van Rhijntrack record | Buy | $85.6K | conv 59 | AMF |
| Bartholomeus van Rhijntrack record | Buy | $46.5K | conv 59 | AMF |
| Bartholomeus van Rhijntrack record | Buy | $99.7K | conv 73First in 12mo | AMF |